Michael Wilsack, MHA

Michael Wilsack, MHA, has extensive experience in sales and account management within the healthcare industry. Michael currently holds the position of Vice President of Sales for SinguLab® in the New England region. Prior to this, they worked as a Territory Sales Manager for Zynex Medical.

From 2020 to 2022, Michael worked as an Immunology Specialist at Syneos Health, where they exceeded sales goals and demonstrated a strong understanding of the buy and bill reimbursement process.

Before that, Michael served as a Senior Account Manager at Eli Lilly and Company from 2018 to 2020, where they consistently exceeded sales goals in the long-term care market.

From 2014 to 2018, Michael worked at Syneos Health Commercial Solutions (previously inVentiv Health Commercial Solutions), first as a Pharmaceutical Sales Representative and later as a Long Term Care Specialist. During this time, they won the Pinnacle Award in 2016 and 2017 for selling Xarelto to long-term care facilities and pharmacies.

Michael's sales career began in 1999 at Novartis Pharmaceuticals, where they worked as a Sales Consultant, selling various medications to primary and specialty physicians. Michael achieved high goal attainment for Zelnorm and played a key role in securing its placement on the 2nd tier status at Blue Cross Blue Shield of Massachusetts.

Throughout their career, Michael has consistently demonstrated strong sales performance, exceeding objectives and quotas. Michael has a proven track record of building relationships with healthcare professionals and successfully selling pharmaceutical and medical products.

Michael Wilsack, MHA, obtained a Bachelor of Science degree in Business Administration and Management, General from Penn State University. Currently, they are pursuing a Master's degree in Master Health Administration at Duquesne University, which is expected to be completed between 2020 and 2022.